Total Visits

Views
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.90

Total Visits Per Month

March 2021April 2021May 2021June 2021July 2021August 2021September 2021
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.0110212

File Downloads

Views
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.pdf58

Top country views

Views
France21
United Kingdom21
Germany16
United States11
China9
South Korea3
Russia2
Brazil1
Italy1
Netherlands1

Top cities views

Views
Paris7
Boardman4
Beijing2
Des Moines2
Hangzhou2
Leeds2
London2
Ashburn1
Exeter1
Ferrara1